Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...
IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...
Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
The study, backed by the WHO, was released to mark World Diabetes Day on Thursday. It conducts a comparison between the ...
People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...
Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...
People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...
Discover how researchers from PGI and NABI are unlocking the anti-diabetic properties of ginger, leading to innovative ...